Dublin, July 15, 2019 (GLOBE NEWSWIRE) -- The "Global Endovenous Ablation Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
Increasing prevalence of CVI
One of the high risk factors for CVI is aging. Therefore, the growing geriatric population will increase the incidence of CVI. Other risk factors include obesity, smoking, and pregnancy, which are also prevalent.
Moreover, CVI is a progressive medical condition, which worsens with time. As a result, the need for effective treatment of CVI is increasing.
Therefore, the sales of endovenous ablation devices have been increasing, which will lead to the expansion of the global endovenous ablation devices market. The market will grow at a CAGR of almost 4% during the forecast period.
Emergence of endovenous steam ablation (EVSA) as an alternative to EVLA & RFA
The EVSA method has better patient tolerance compared with EVLA and RFA. This factor is attributed to the minute and flexible catheter of EVSA compared with the stiff glass fibers of EVLA and RFA. EVSA catheters can easily be inserted into veins without inflicting pain on the patient.
Therefore, the emergence of EVSA as an alternative to EVLA and RFA will have a positive impact on the overall market growth.
Market Dynamics
The report has observed market growth factors such as the increasing prevalence of CVI, growing demand for MI endovenous ablation procedures, and technological advances in endovascular ablation devices.
However, challenges such as high cost coupled with unfavorable reimbursement policies, limitations and complications associated with endovenous ablation techniques, and shortage of skilled vascular surgeons may hamper the growth of the endovenous ablation devices industry over the forecast period.
Segments Analyzed
This endovenous ablation devices market analysis considers sales from the endovenous laser ablation therapy (EVLT) devices, radiofrequency ablation (RFA) devices, and non-thermal non-tumescent (NTNT) devices segments. The analysis also considers the sales of endovenous ablation devices in Asia, Europe, North America, and RoW.
In 2018, the EVLT segment held the highest market share. This trend is expected to remain prevalent over the forecast period. Factors such as the high success rate of EVLT devices compared with others and their ability to perform minimally invasive procedures without spinal or general anesthesia are helping the EVLT segment in maintaining its leading market position.
Competitive Landscape
With the presence of a few major players, the global endovenous ablation devices market is concentrated. This robust vendor analysis is designed to help clients in improving their market positions, and in line with this, this report provides a detailed analysis of several leading endovenous ablation devices manufacturers which include:
- AngioDynamics Inc.
- Medtronic PLC
- Sciton Inc.
- Teleflex Inc.
- Venclose Inc.
Also, the endovenous ablation devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Key Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY TECHNOLOGY
- Comparison by technology
- EVLT devices - Market size and forecast 2018-2023
- RFA devices - Market size and forecast 2018-2023
- NTNT devices - Market size and forecast 2018-2023
- Market opportunity by technology
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- RoW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
- Increasing popularity of performing endovenous procedures in an outpatient setting
- Emergence of endovenous steam ablation (EVSA) as an alternative to EVLA and RFA
- Strategic partnerships, M&A, and marketing initiatives by vendors
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- AngioDynamics Inc.
- Medtronic PLC
- Sciton Inc.
- Teleflex Inc.
- Venclose Inc.
For more information about this report visit https://www.researchandmarkets.com/r/ct6rg9
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.